EQS-Ad-hoc: Semperit AG Holding / Key word(s): Strategic Company Decision/Disposal Disclosed inside information / Ad hoc release Vienna, Austria, 16.12.2022 – Semperit AG Holding has reached an agreement with the Southeast Asian glove producer HARPS GLOBAL PTE. LTD., based in Singapore with production facilities in Malaysia, on the sale of its medical business (Sempermed; surgical and examination gloves). The contract was signed in Vienna today. The execution of the transaction is subject to the approval of the competent authorities; it is expected for the second quarter of 2023. Initially, the production of surgical gloves in Wimpassing, Austria, and their packaging in Sopron, Hungary, will be excluded from the transaction and will continue as contract manufacturing for the buyer for several years. The sales price (cash and debt free) is EUR 115 million and is subject to customary price adjustment mechanisms upon completion of the transactions. In this context, an impairment reversal in the order of approximately EUR 30-35 million for the assets of Sempermed is expected; the exact amount will be announced with the publication of the annual results for 2022 on 22 March 2023.
Monika Riedel
www.linkedin.com/company/semperit-ag About Semperit The publicly listed company Semperit AG Holding is an internationally oriented group that develops and produces highly specialised polymer products for the industrial and medical sectors, selling them in over 100 countries around the world: hydraulic and industrial hoses, conveyor belts, escalator handrails, construction profiles, cable car rings, products for railway superstructures, and examination and surgical gloves. Founded in 1824, this long-standing Austrian company has its headquarters in Vienna, Austria. The Semperit Group employs around 7,000 people worldwide, including some 3,800 in Asia and approximately 900 in Austria (Vienna and production site Wimpassing, Lower Austria). The Group has 16 manufacturing facilities worldwide and numerous sales offices in Europe, Asia, Australia, and America. In the 2021 financial year, the Group generated revenue of EUR 1,182.2 million and an EBITDA of EUR 361.8 million.
16-Dec-2022 CET/CEST News transmitted by EQS Group AG. www.eqs.com |
Language: | English |
Company: | Semperit AG Holding |
Am Belvedere 10 | |
1100 Wien | |
Austria | |
Phone: | +43 1 79 777-310 |
Fax: | +43 1 79 777-602 |
E-mail: | judit.helenyi@semperitgroup.com |
Internet: | www.semperitgroup.com |
ISIN: | AT0000785555 |
Listed: | Vienna Stock Exchange (Official Market) |
EQS News ID: | 1515465 |
End of Announcement | EQS News Service |
|
1515465 16-Dec-2022 CET/CEST
The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.
The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.
If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.
For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.
1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.